购物车
全部删除
您的购物车当前为空
PROTACc-Met degrader-5 (Compound D19) 是一种口服活性的c-Met PROTAC降解剂,在EBC-1和Hs746T细胞中的DC50分别为0.42 nM和0.32 nM。它显著诱导细胞凋亡(apoptosis)、G1期细胞周期阻滞,并抑制细胞迁移和侵袭。此化合物对c-Met依赖性癌细胞和Tepotinib耐药性癌细胞表现出强效的抗增殖及降解作用。
PROTACc-Met degrader-5 (Compound D19) 是一种口服活性的c-Met PROTAC降解剂,在EBC-1和Hs746T细胞中的DC50分别为0.42 nM和0.32 nM。它显著诱导细胞凋亡(apoptosis)、G1期细胞周期阻滞,并抑制细胞迁移和侵袭。此化合物对c-Met依赖性癌细胞和Tepotinib耐药性癌细胞表现出强效的抗增殖及降解作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
PROTAC c-Met degrader-5 相关产品
| 产品描述 | PROTACc-Met degrader-5 (Compound D19) is an orally active c-Met PROTAC degrader, with a DC50 of 0.42 nM in EBC-1 cells and 0.32 nM in Hs746T cells. It effectively induces apoptosis, causes G1 cell cycle arrest, and inhibits cell migration and invasion. This compound shows strong antiproliferative and degradative effects on c-Met-dependent cancer cells and those resistant to Tepotinib. |
| 体内活性 | PROTAC c-Met degrader-5 (5-10 mg/kg,口服,每日一次,持续 18 天) 能有效抑制 EBC-1 异种移植小鼠模型的肿瘤生长。 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容